and Molecular Diagnostic
8th Edition by Nader Rifai, Ph
Chapters 1 - 4
,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
TH TH TH TH TH TH TH TH
TH
TH TH
Table of contents:
TH TH
I. Principles Of Laboratory Medicine
TH TH TH TH
Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
TH TH TH TH TH TH TH TH
Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
TH TH TH TH TH TH TH TH TH TH TH
Chapter 3. Clinical Evaluation of Methods
TH TH TH TH TH
Chapter 4. Evidence-Based Laboratory Medicine
TH TH TH TH
Chapter 5. Establishment and Use of Reference Values
TH TH TH TH TH TH TH
Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
TH TH TH TH TH TH TH TH
Chapter 7. Quality Management
TH TH TH
II. Analytical Techniques And Instrumentation
TH TH TH TH
Chapter 8. Principles of Basic Techniques and Laboratory Safety
TH TH TH TH TH TH TH TH
Chapter 9. Optical Techniques
TH TH TH
Chapter 10. Electrochemistry and Chemical Sensors
TH TH TH TH TH
Chapter 11. Electrophoresis
TH TH
Chapter 12. Chromatography
TH TH
Chapter 13. Mass Spectrometry
TH TH TH
Chapter 14. Enzyme and Rate Analyses
TH TH TH TH TH
Chapter 15. Immunochemical Techniques
TH TH TH
Chapter 16 Automation
TH TH
Chapter 17. Point-of-Care Instrumentation
TH TH TH
III. Analytes
T H
Chapter 18. Amino Acids, Peptides, and Proteins
TH TH TH TH TH TH
Chapter 19. Serum Enzymes
TH TH TH
Chapter 20. Tumor Markers and Cancer Genes
TH TH TH TH TH TH
Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
TH TH TH TH TH TH TH TH TH TH TH
Chapter 22. Carbohydrates
TH TH
Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
TH TH TH TH TH TH TH TH TH
Chapter 24. Electrolytes and Blood Gases
TH TH TH TH TH
Chapter 25. Hormones
TH TH
Chapter 26. Catecholamines and Serotonin
TH T H TH TH
Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
TH T H TH TH TH TH
Chapter 28. Hemoglobin, Iron, and Bilirubin
TH TH TH TH TH
Chapter 29. Porphyrins and Porphyrias
TH TH TH TH
Chapter 30. Therapeutic Drugs and Their Management
TH TH TH TH TH TH
Chapter 31. Clinical Toxicology
TH TH TH
Chapter 32. Toxic Metals
TH T H TH
IV. Pathophysiology
T H
Chapter 33. Diabetes
TH TH
,Chapter 34. Cardiovascular Disease
TH T H TH
Chapter 35. Kidney Disease
TH TH TH
Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
TH T H TH TH TH TH TH TH TH TH
Chapter 37. Liver Disease
TH THTH TH
Chapter 38. Gastrointestinal and Pancreatic Diseases
TH T H TH TH TH
Chapter 39. Disorders of Bone and Mineral Metabolism
TH THTH TH TH TH TH TH
Chapter 40. Disorders of the Pituitary Gland
TH THTH TH TH TH TH
Chapter 41. Disorders of the Adrenal Cortex
TH T H TH TH TH TH
Chapter 42. Thyroid Disorders
TH T H TH
Chapter 43. Reproduction-Related Disorders
TH T H TH
Chapter 44. Pregnancy and Prenatal Testing
TH THTH TH TH TH
Chapter 45. Newborn Screening and Inborn Errors of Metabolism
TH T H TH TH TH TH TH TH
Chapter 46. Pharmacogenetics
TH TH
V. Molecular Diagnostics
T H TH
Chapter 47. Principles of Molecular Biology
TH TH TH TH TH
Chapter 48. Nucleic Acid Techniques and Applications
TH TH TH TH TH TH
Chapter 49. Genomes and Nucleic Acid Alterations
TH TH TH TH TH TH
, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine TestBan
TH TH TH TH TH TH TH TH TH H
T
k
MULTIPLE CHOICE TH
1. An individual working in a clinical chemistry laboratory is married to a sales representativ
TH TH TH TH TH TH TH TH TH TH TH TH TH
e who works for a company that sells chemistry laboratory supplies. When the laboratory
TH TH TH TH TH TH TH TH TH TH TH TH TH T
manager requests a list of needed supplies, cost of supplies, and vendors, this individual
H TH TH TH TH TH TH TH TH TH TH TH TH TH TH
onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
TH TH TH TH TH TH TH TH TH TH TH TH TH
a. accounting issue. TH
b. possible conflict of interest. TH TH TH
c. maintenance of confidentiality issue. TH TH TH
d. problem with resource allocation. TH TH TH
ANS: B TH
Concern has been raised over the interrelationships between practitioners in the medical f
TH TH TH TH TH TH TH TH TH TH TH TH
ieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession
TH TH TH TH TH TH TH TH TH TH TH TH
.
Similarly, relationships have been scrutinized between clinical laboratorians and manufactu
TH TH TH TH TH TH TH TH TH
rers and providers of diagnostic equipment and supplies. These concerns led the National I
TH TH TH TH TH TH TH TH TH TH TH TH TH
nstitutes of Health (NIH) in 1995 to require official institutional review of financial disclosur
TH TH TH TH TH TH TH TH TH TH TH TH TH
e by researchers and management of situations in which disclosure indicates potentialconfli
TH TH TH TH TH TH TH TH TH TH TH TH
cts of interest.
TH TH
DIF: 1 REF: Page 4-5 THTHTH TH OBJ: 6 | 7 TH TH TH
2. A patient visits her physician stating that her prescribed painkiller is not working to redu
TH TH TH TH TH TH TH TH TH TH TH TH TH TH
ce the pain following her recent surgery. A friend of the patient claims that the same pai
TH TH TH TH TH TH TH TH TH TH TH TH TH TH TH TH
nkiller“worked wonders” to reduce her pain after the same surgery. The physician states
TH TH TH TH TH TH TH TH TH TH TH TH TH
that the difference in the effect of the drug might be caused by
TH TH TH TH TH TH TH TH TH TH TH TH TH
, which is studied in pharmacogenetics.
TH TH TH TH TH
a. epidemiology
b. an inherited disease TH TH
c. a conflict of interest TH TH TH
d. a genetic variation in drug-metabolizing enzymes
TH TH TH TH TH
ANS: D TH
Pharmacogenetics is the study of the genetic variation of drug metabolism betw TH TH TH TH TH TH TH TH TH TH TH
eenindividuals. TH
DIF: 1 REF: Page 3 THTHTH TH OBJ: 1 TH
3. John works in a molecular diagnostics laboratory and receives a blood sample that has t
TH TH TH TH TH TH TH TH TH TH TH TH TH TH
he name of a close friend printed on the bar-
TH TH TH TH TH TH TH TH TH
coded label. The genetic test that is ordered on thefriend’s sample would provide diagn
TH TH TH TH TH TH TH TH TH TH TH TH TH TH
ostic information about a disorder that has a poor prognosis, and the test is usually perf
TH TH TH TH TH TH TH TH TH TH TH TH TH TH TH
ormed by John. He asks a fellow employee to analyzethe sample for him and not divulge
TH TH TH TH TH TH TH TH TH TH TH TH TH TH TH TH
the results. This ethical issue concerns:
TH TH TH TH TH TH
a. confidentiality of patient genetic and medical information. TH TH TH TH TH TH
b. a conflict of interest. TH TH TH
c. resource allocation. TH
d. diagnostic accuracy. TH